CIK 1830162

4D pharma plc

CIK 0001830162 · EDGAR ↗

cleanelevatedtriggeredno dataplanned

82.3

composite · 3 signals · TRIGGERED

Every card below shows the score and the exact filing data it was computed from — no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded — never a guess.

Chat with this filing →

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo — generate one →

Run the bounded investigation agent — reads this company's signals and writes a short, cited summary.

Signals

P-13 · FY 2021-12-31 · TRIGGERED100.0

Zombie / distress

Zombie: interest coverage below 1.0x for 4 consecutive years

trend: flat

Trend

Source: 20-F on SEC.gov (filed 2022-03-31) ↗

Evidence — inputs and thresholds

{
  "icr_by_year": {
    "2021-12-31": -64.133,
    "2020-12-31": -5835,
    "2019-12-31": -516.167,
    "2018-12-31": -12963.333
  },
  "consecutive_years_below_1": 4,
  "altman_z_double_prime": -9.848,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -37261000,
    "interest_expense_t": 581000
  },
  "stale": false,
  "latest_filing_period": "2021-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1830162/000149315222008593/0001493152-22-008593-index.htm",
    "form": "20-F",
    "filed": "2022-03-31"
  }
}

P-01 · FY 2021-12-31 · ELEVATED37.6

Earnings quality

Accruals at 11% of assets — aggressive

trend: flat

Trend

Source: 20-F on SEC.gov (filed 2022-03-31) ↗

Evidence — inputs and thresholds

{
  "m_score": -2.379,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 1,
    "GMI": 1,
    "AQI": 0.732,
    "SGI": 1.041,
    "DEPI": 0.93,
    "SGAI": 1.173,
    "LVGI": 1.812,
    "TATA": 0.102
  },
  "defaulted_to_neutral": [
    "DSRI",
    "GMI"
  ],
  "sloan_accruals": 0.1108,
  "inputs": {
    "revenue_t": 718000,
    "revenue_t1": 690000,
    "total_assets_t": 58794000,
    "net_income_t": -31938000,
    "cfo_t": -37916000
  },
  "stale": false,
  "latest_filing_period": "2021-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1830162/000149315222008593/0001493152-22-008593-index.htm",
    "form": "20-F",
    "filed": "2022-03-31"
  }
}

P-12 · FY 2021-12-31 · CLEAN30.0

Restatement predictor

F-Score 0.90 — at or below the population base rate

trend: flat

Trend

Source: 20-F on SEC.gov (filed 2022-03-31) ↗

Evidence — inputs and thresholds

{
  "f_score": 0.899,
  "probability": 0.00333,
  "components": {
    "rsst": 0.1108,
    "drec": null,
    "dinv": null,
    "soft": 0.5757,
    "dcs": 0.0406,
    "droa": 0.0779,
    "issue": 1
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2021-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1830162/000149315222008593/0001493152-22-008593-index.htm",
    "form": "20-F",
    "filed": "2022-03-31"
  }
}